Cobra venom is deadly stuff (about 20,000 fatalities a year globally), but it may also be a healer. A new drug derived from the venom has shown promise against multiple sclerosis (MS) and sister diseases affecting the nervous and immune systems. PhyloMed, a pharmaceutical company in Plantation, Fla., has synthesized a harmless peptide (small protein) from constituents of the snake’s venom, that acts as a kind of decoy. Attacks by immune system cells on myelin-the fatty material surrounding nerve fibers-disrupt signals between nerve cells to create characteristic MS lesions and paralysis. Neurotoxins from cobra venom paralyze nerve cells in much the same way. By binding to nerve cell receptors as a modified peptide instead of as a toxin, the venom-derived drug, called Immunokine, morphs into a therapeutic agent that can reverse MS’s debilitating effects. Clinical trials slated for this summer will target MS and adrenomyeloneuropathy (a progressive genetic disorder of the adrenal gland that results in nervous system deterioration).
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
How do strong muscles keep your brain healthy?
There’s a robust molecular language being spoken between your muscles and your brain.
The 1,000 Chinese SpaceX engineers who never existed
LinkedIn users are being scammed of millions of dollars by fake connections posing as graduates of prestigious universities and employees at top tech companies.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.